IDENTITY

GC ADDA is a network of drug discovery researchers working in Africa on unmet medical needs faced by the African patient.

MISSION

To establish a sustainable network that accelerates drug discovery for unmet medical needs in Africa. We aim to develop and retain a critical mass of talented researchers in Africa while creating globally-connected, regional centers of excellence that nourish the drug discovery pipeline

VISION

A future where African patients thrive from innovative drug discovery solutions tailored to their health needs.

Current

Member Countries

  • CAMEROON

    Full Members: 

    Fabrice Boyom (University of Yaounde 1/ Advanced Research & Health Innovation Hub)

    Fidele Ntie-Kang (University of Buea)

  • GHANA

    Full Members:

    Richard Amewu (University of Ghana) 


    Associate Members: 

    Arnold Forkuo Donkor (Kwame Nkrumah University of Science and Technology)

  • KENYA

    Full Members: 

    Edwin Murungi (Kisii University)

    Elizabeth V. M. Kigondu (Kenya Medical Research Institute)

  • MALI

    Full Members:

    Dinkorma Ouologuem Toure (Université des Sciences, des techniques et des Technologies de Bamako)

    Laurent Dembele (Malaria Research and Training Centre)

  • NIGERIA

    Associate Members: 

    Iruka Okeke (University of Ibadan)

    John Ogbaji Igoli (Joseph Sarwuan Tarka University)

  • SOUTH AFRICA

    Full Members: 

    Adrienne Edkins (Rhodes University)

    Amanda Rousseau (University of the Witwatersrand)

    Erick Strauss (Stellenbosch University)

    Fortunate Mokoena (North-West University)

    Gabriel Mashabela (Stellenbosch University/South African Research Council)

    Kelly Chibale (H3D, University of Cape Town)

    Lyn-Marie Birkholtz (University of Pretoria)

    Rajshekhar Karpoormath (University of KwaZulu-Natal)

    Rose Hayeshi (North-West University)

    Susan Winks (H3D, University of Cape Town)

    Vinayak Singh (H3D, University of Cape Town)

    Winston Nxumalo (University of Limpopo)


    Associate Members: 

    Candice Soares de Melo (H3D, University of Cape Town)

    Liezl Krugmann (H3D, University of Cape Town)

    Mathew Njoroge (H3D, University of Cape Town)

    Mwila Mulubwa (H3D, University of Cape Town)

  • ZAMBIA

    Full Members: 

    Peter Mubanga Cheuka (The University of Zambia)

  • ZIMBABWE

    Full Members: 

    Collen Masimirembwa (African Institute for Biomedical Research)

    Grace Mugumbate (Midlands State University)


    Associate Members: 

    Ali Mohamed Ali (African Institute of Biomedical Science and Technology)

    Roslyn Stella Thelingwani (African Institute of Biomedical Science and Technology)

Press

  • African Research Partners Consolidate Network to Accelerate Continental Drug Discovery

    Nearly two decades ago, South African researcher Kelly Chibale recalls participating in a pioneering World Health Organization (WHO) meeting in Abuja, Nigeria, organized by TDR, the WHO-hosted Special Programme for Research and Training in Tropical Diseases, focusing on the concept of an African drug discovery network. 


    Read More

  • LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa

    LifeArc and the Bill & Melinda Gates Foundation are jointly investing £6 million ($7.2m) in the Grand Challenges African Drug Discovery Accelerator (GC ADDA) programme, a collaboration that will support 5 African drug discovery projects over 3 to 5 years.




    Read More

  • African scientists secure major grants to accelerate drug discovery

    A network of world-class scientists across Africa has entered the global drug discovery arena following a US$7.2 million joint investment by the medical research charity LifeArc and the Bill & Melinda Gates Foundation in the Grand Challenges Africa Drug Discovery Accelerator (GC ADDA) programme.


    Grand Challenges is a family of initiatives fostering innovation to solve key global health and development problems.

    Read more

  • Developing drug discovery initiatives for Africa, out of Africa

    The Holistic Drug Discovery and Development Centre (H3D) is a case in point. It has achieved remarkable milestones as Africa’s first integrated drug discovery centre. Founded in 2010 and accredited by the University of Cape Town (UCT), H3D has established a world-class integrated drug discovery infrastructure and delivered Africa’s first clinical candidate for malaria, showcasing the potential of Africa-led research.


    Read more

Get in Touch

Whether you are interested in joining one of our memberships or have general questions about our organisation, you can contact us via the form provided.
We aim to respond promptly to every enquiry.

Contact Us